site stats

Jasper therapeutics inc. jspr

Web31 ian. 2024 · Jasper Therapeutics, Inc. is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic … Web13 apr. 2024 · Furthermore, Jasper Therapeutics Inc. (JSPR)’s average true range (ATR) is 0.13. The company’s stock has been forecasted to trade at an average price of $6.21 …

Jasper Therapeutics, Inc. Common Stock (JSPR) - Nasdaq

Web6 apr. 2024 · Further, Jasper Therapeutics Inc. (JSPR) has a beta value of 0, and an average true range (ATR) of 0.14. Analysts have given the company’s stock an average 52-week price target of $6.21, forecast between a low of $4.00 and high of $8.00. Looking at the price targets, the low is -158.06% off current price level while to achieve the yearly ... Web10 apr. 2024 · Jasper Therapeutics, Inc. kondigde de benoeming aan van David Hinds tot Senior Vice President, Development Operations. De heer Hinds brengt meer dan 25 jaar ervaring mee in operaties en klinische... 13 april 2024 gi joe game switch https://mrhaccounts.com

公告正文 _ 数据中心 _ 东方财富网

WebJasper Therapeutics, Inc. Common Stock (JSPR) Nasdaq Listed. CLOSED AT 4:00 PM ET ON Jul 05, 2024. DATA AS OF Jul 05, 2024 7:05 PM ET - AFTER HOURS. Add to Watchlist. Add to Portfolio. Web14 feb. 2024 · About Jasper Therapeutics, Inc. 2200 BRIDGE PARKWAY SUITE NO. 102, REDWOOD, California, 94065, United States +1 650 549-1400 … WebTodo sobre el precio de las acciones de Jasper Therapeutics en bolsa (NASDAQ:JSPR), con gráficos, análisis y más sobre la cotización de Jasper Therapeutics (Acciones JSPR). ftir predictor

Jasper Therapeutics, Inc. (JSPR) Stock Price, Quote

Category:Jasper Therapeutics (JSPR) Stock Price & Analysis - TipRanks

Tags:Jasper therapeutics inc. jspr

Jasper therapeutics inc. jspr

Jasper Therapeutics Appoints David Hinds as Senior Vice President ...

Web6 apr. 2024 · Detailed statistics for Jasper Therapeutics, Inc. (JSPR) stock, including valuation metrics, financial numbers, share information and more. ... The beta is 2.02, so JSPR's price volatility has been higher than the market average. Beta (1Y) 2.02: 52-Week Price Change -57.51%: 50-Day Moving Average 1.84: 200-Day Moving Average 1.47: … WebJasper Therapeutics Inc. 2200 Bridge Parkway. Suite 102. Redwood City, California 94065. Phone 1 650 549-1400. Industry Biotechnology. Sector Health Care/Life Sciences.

Jasper therapeutics inc. jspr

Did you know?

Web10 apr. 2024 · Jasper Therapeutics, Inc. a annoncé la nomination de David Hinds au poste de premier vice-président des opérations de développement de la société. ... JSPR US4718711033. JASPER THERAPEUTICS ... WebJasper Therapeutics to Present at Cantor Fitzgerald’s The Future of Oncology Virtual Symposium. REDWOOD CITY, Calif., March 31, 2024 (GLOBE NEWSWIRE) -- Jasper …

Web14 apr. 2024 · Jasper Therapeutics Inc (JSPR) stock is trading at $1.45 as of 10:38 AM on Friday, Apr 14, a loss of -$0.05, or -3.33% from the previous closing price of $1.50. The … Web6 apr. 2024 · Jasper Therapeutics, Inc. is a biotechnology company. The Company is engaged in the development and commercialization of therapeutic agents for diseases, such as Chronic Spontaneous Urticaria (CSU), Lower to Intermediate Risk Myelodysplastic Syndrome (LR-MDS) and conditioning regimens for stem cell transplantation and ex-vivo …

WebJasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of … Web마감 후 결합된 회사는 Jasper Therapeutics, Inc.로 운영되며 2024년 9월 27일경에 의결권 있는 보통주와 신주인수권의 주식이 시장에서 거래를 시작할 것으로 예상됩니다. 나스닥 …

Web28 mar. 2024 · Jasper Therapeutics Inc. (JSPR) full year performance was -47.31%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Jasper Therapeutics Inc. shares are logging -59.74% during the 52-week period from high …

WebAcum 2 zile · The Trade: Jasper Therapeutics, Inc. (NASDAQ:JSPR) 10% owner Gary Rieschel acquired a total 2,666,666 shares an average price of $1.50. To acquire these shares, it cost around $4 million. ftir price rangeWebJasper Therapeutics Inc- May Offer, Sell Shares Of Our Common Stock Of Up To $15.5 Million From Time To Time Through Or To Cantor Fitzgerald. Nov 10, 2024Reuters. Jasper Therapeutics Inc Reports Quarterly Loss Per Share Of $0.32. Oct 7, 2024Reuters. Jasper Therapeutics Files For Mixed Shelf Of Up To $150 Million. ftir pros and consWeb10 apr. 2024 · Jasper Therapeutics Appoints David Hinds as Senior Vice President, Development Operations. REDWOOD CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) … ftir procedure pdf